Prevalence of Human Papillomavirus in women of the Yaracuy State
Keywords:
Detection, Genotypes, Prevalence, Human Papillomavirus (HPV)Abstract
Human Papillomavirus (HPV) is a common virus associated with cervical cancer. Its detection and genotyping are crucial for prevention. A study in Yaracuy State, Venezuela, evaluated 108 women, finding a 27.78% prevalence of HPV, with genotypes 16 and 18 being the most frequent. Although no high-grade lesions were found, the importance of early detection is highlighted. Statistical analysis revealed a homogeneous age distribution among participants. Cytological results mainly showed moderate inflammation. HPV molecular detection was performed using high-performance tests. Although Venezuela still relies on cytology for cervical cancer screening, there is a call to consider HPV testing to improve diagnostic accuracy. This study provides a detailed view of HPV epidemiology in the region and emphasizes the need to update screening programs.
References
Haręża DA, Wilczyński JR, Paradowska E. Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins. Int J Mol Sci. 2022 Feb 5;23(3):1818. doi: 10.3390/ijms23031818.
Ghittoni R, Accardi R, Chiocca S, Tommasino M. Role of human papillomaviruses in carcinogenesis. Ecancermedicalscience. 2015;9:1–9.
Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Practice and Research: Clinical Obstetrics and Gynaecology [Internet]. 2018;47:14–26. Available from: https://doi.org/10.1016/j.bpobgyn.2017.08.006
Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, et al. The biology and life-cycle of human papillomaviruses. Vaccine. 2012;30(SUPPL.5):F55–70. http://dx.doi.org/10.1016/j.vaccine.2012.06.083
Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016 Dec 22;2:16086.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.
Capote Negrín L. Resumen del cáncer en Venezuela. 2012. Rev Venez Oncol. 2015;27(4):256–68.
International Agency for Research on Cancer [Internet]. [Revisado el 05 de septiembre de 2023]. Disponible en: https://gco.iarc.fr/today/data/factsheets/populations/862-venezuela-bolivarian-republic-of-fact-sheets.pdf.
Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131:2349–59.
Ávila M, Genatios U, Blanch R, de Guglielmo Z, Fernandes A, Veitía D, et al. Genotipificación de virus de papiloma humano en mujeres con lesiones de cuello uterino. Revista Venezolana de Oncologia. 2013;25(3):157–65.
Correnti M, Medina F, Cavazza ME, Rennola A, Ávila M, Fernandes A. Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women. Gynecologic Oncology [Internet]. 2011;121(3):527–31. Available from: http://dx.doi.org/10.1016/j.ygyno.2011.02.003
Nayar R and Wilbur D (2015) The Pap Test and Bethesda 2014 Acta Cytol 59(2) 121–132 https://doi.org/10.1159/000381842 PMID: 25997404
De Sanjosé S, Díaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007; 7: 453-459.
Latan J, Fernandes A, López M, Fermín M, Correnti M. Detección de la infección por Virus de Papiloma Humano en ano en pacientes con lesiones en cuello uterino. Rev Obstet Ginecol Venez. 2017;7(2):92-99.
Toro M, López M. Infección por virus papiloma humano en pacientes con citología de cuello uterino negativa. Rev Obstet Ginecol Venez 2017;77(1):11 - 20
Kusakabe M, Taguchi A, Sone K, Mori M, Osuga Y. Carcinogenesis and management of human papillomavirus-associated cervical cancer. Int J Clin Oncol. 2023 Aug;28(8):965-974. doi: 10.1007/s10147-023-02337-7.
Perkins RB, Wentzensen N, Guido RS, Schiffman M. Cervical Cancer Screening: A Review. JAMA. 2023; 8;330(6):547-558.
Kalantari M, García A, Morales C, Zuna R, Pérez D, Calleja I, et al. Laser Capture Microdissection of Cervical Human Papillomavirus Infections: Copy Number of the Virus in Cancerous and Normal Tissue and Heterogeneous DNA Methylation. Virology. 2009; 390(2): 261-267.
Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. J Low Genit Tract Dis 2015;19:91–6.
Viveros-Carreño D, Fernandes A, Pareja R. Updates on cervical cancer prevention. Int J Gynecol Cancer. 2023 Mar 6;33(3):394-402. doi: 10.1136/ijgc-2022-003703. PMID: 36878567.
Gomes M, Moura N, Magalhães L, Silva R, Silva B, Rodrigues IR, et al. Systematic literature review of primary and secondary cervical cancer prevention programs in South America. Rev Panam Salud Publica. 2023;47:e96.
Fernandes A, Pérez M, Ávila M, Fuenmayor J, Karolinski A, Hoegl J. Perspectiva actual sobre la prevención del cáncer de cuello uterino en Venezuela. Valoración mediante una encuesta. Rev Obstet Ginecol Venez. 2022; 82 (3): 340-349.
World Health Organization [Internet]. Ginebra: Global strategy to accelerate the elimination of cervical cancer as a public health problem; 2020 [consultado el 06 de septiembre de 2023]. License: CC BY-NC-SA 3.0 IGO. Disponible en: https://https://www.who.int/publications/i/item/9789240014107
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Multidisciplinary & Health Education Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
